InTest Reports Q4 2025 EPS of $0.10 with Revenue of $32.8 Million Amidst Improving Momentum

About this update from Intest Corporation

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/80b73185816e613a6fbdaa1ea5492292"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/9dHzaY1FrWP6BU57HbCsIw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/80b73185816e613a6fbdaa1ea5492292","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/L.O34xmOq0mj3T0Q2FbMqQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/80b73185816e613a6fbdaa1ea5492292","width":1024,"height":512}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Orders1 of $37.5 million driven by continued strength in Auto/EV and Life Sciences; Backlog1 up 9.4% sequentially","length":113,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Gross margin expanded 350 basis points sequentially to 45.4%","length":60,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Nearly 80% of revenue derived from non-semiconductor end markets","length":64,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Maintained balance sheet strength; reduced total debt by $7.6 million from December 31, 2024","length":92,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":329,"olType":false},{"type":"text","content":"MT. LAUREL, N.J., February 27, 2026--(BUSINESS WIRE)--InTest Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include semiconductor ("Semi"), Auto/EV, Defense/Aerospace, Industrial, Life Sciences, and Safety/Security, today announced financial results for the fourth quarter of 2025 ended December 31, 2025.","length":438,"tagName":"p"},{"type":"text","content":""Orders remained strong at $37.5 million for the fourth quarter as Auto/EV customers moved forward with new model year programs coupled with the success we are seeing with the diversification in Life Sciences. We continue to see improved customer spending sentiment across our increasingly diversified markets. As a result, our 2025 year-end backlog was a healthy $53.9 million, an increase of 36...

More updates from Intest Corporation